Please click on the links below to learn more about the trials currently open at Carolina BioOncology Institute:

A Phase I Study of CDX1307, hCG-B Vaccine, in Patients with Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder and Ovarian Cancer.
http://www.clinicaltrials.gov/ct2/show/NCT00648102?

A Phase I Study of Ovarian Cancer Peptides Plus GM-CSF and Adjuvant (Montanide ISA-51) as Consolidation Following Optimal Debulking and Systemic Chemotherapy for Women With Advanced Stage Ovarian, Tubal or Peritoneal Cancer
http://clinicaltrials.gov/ct2/show/NCT00437502?term=ovarian+immunotope&rank=1

A Multi Center Treatment Protocol for Compassionate Use of Ipilimumab (BMS-734016) Monotherapy in Subjects with Unresectable Stage II or Stage IV Melanoma (IMEXA)
http://www.clinicaltrials.gov/ct2/show/NCT00495066?term=IMEXA&rank=1

A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated Her2 Positive Metastatic Breast Cancer (CLEOPATEA)
http://www.clinicaltrials.gov/ct2/show/NCT00567190?term=Cleopatra&rank=1

A Phase I, Open-Label, Dose-Escalation, Multidose Study of CDX-1307, a Mannose Receptor-Targeted hCG-β Vaccine, in Patients with Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer
http://www.clinicaltrials.gov/ct2/show/NCT0070946?

A Phase Ib, Open-label, Multi-dose, Multicenter, Dose-Escalation Study of MDX-1106 in Subjects with Selected Advanced or Recurrent Maligancies
http://www.clinicaltrials.gov/ct2/show/NCT00730639?term=MDX-1106&rank=1

A Phase III Study of Rituximab Alternating Dosing Rate in Patients with Diffuse Large B Cell or Follicular Non-Hodgkin's Lymphoma (RATE)
http://www.clinicaltrials.gov/ct2/show/NCT00719472?term=U4391g&rank=1

A Study of Afibercept Versus Placebo in Patients with Second Line Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)(VITAL)
http://www.clinicaltrials.gov/ct2/show/NCT00532155?term=efc10261&rank=1